261 – 270 of 797
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Erythroid Culture Based on Differentiation of Progenitor Cells from Leftover Buffy Coats Produced in the Reveos Automated Blood Processing System
2017) 27th Regional Congress of the International Society of Blood Transfusion, ISBT 2017 In Vox Sanguinis 112(supp 1). p.288-288(
- Contribution to journal › Published meeting abstract
-
Mark
Incidence and outcome of acquired aplastic anemia : Real-world data from patients diagnosed in Sweden from 2000–2011
(
- Contribution to journal › Article
-
Mark
SHARPIN stabilizes estrogen receptor a and promotes breast cancer cell proliferation
(
- Contribution to journal › Article
-
Mark
Bioinformatic approaches to gene expression in leukemia. Networks and deconvolution
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Linear decline of corrected platelet count increment within 24 hours after platelet transfusion in haematological patients : a prospective observational study
(
- Contribution to journal › Article
-
Mark
Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1
(
- Contribution to journal › Article
-
Mark
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors : a multicenter IMWG study
(
- Contribution to journal › Article
-
Mark
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations
(
- Contribution to journal › Article
-
Mark
The P1 histo-blood group antigen is present on human red blood cell glycoproteins
2017) 27th Regional Congress of the International Society of Blood Transfusion, ISBT 2017 In Vox Sanguinis 112(S1). p.25-25(
- Contribution to journal › Published meeting abstract
-
Mark
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone : A pooled analysis
(
- Contribution to journal › Article